This page contains a Flash digital edition of a book.
PEER-REVIEW | DERMATOLOGY | Anaesthesia Application techniques


TOPICAL ANAESTHESIA BLT Cream (Benzocaine 20%/Lidocaine 6%/Tetracaine 4%) topical anaesthetic given 1 hour before before treatment


■ Apply to entire facial area, with particular care at the periorbital areas and other lateral facial regions not easily covered by a regional block


REGIONAL ANAESTHESIA The author typically gave regional anaesthesia during the procedure


REGIONAL AREA Supraorbital and supratrochlear nerve block


METHOD ■ Locate supraorbital foramen and insert needle. Lateral to supraorbital foramen. Direct needle medially, parallel to brow, toward nose


■ Infiltrate the mid-two thirds of the lower edge of eyebrow. Use 1 cc of 1–2% Lidocaine. Inject just above bone level


REGIONAL AREA Infraorbital nerve block


METHOD ■ Locate infraorbital foramen


■ Insert needle. Insert inferior to the foramen by 1 cm (slightly medial). Direct needle toward supraorbital foramen. Avoid approaching orbit


■ Infiltrate at infraorbital foramen. Use 1 cc of 1–2% Lidocaine. Inject just above bone level


REGIONAL AREA Mental nerve block


METHOD ■ Locate mental foramen ■ Insert needle. Insert 1.5 cm posterolateral to the mental foramen Direct needle toward mental foramen. Avoid approaching orbit


■ Infiltrate at mental foramen. Use 1 cc of 1–2% Lidocaine. Inject just above bone level The patients were treated under topical and


regional anaesthetic. IV sedation was not required for any patients, although 5 mg of midazolam can provide useful anxiolysis if required.


■ 30 W DOT mode ON, spacing 300–500 µm, scan dwell time 500–800 µs


■ 30 W DOT mode ON, spacing 300–1000 µm, scan dwell time 2000, stack 2 or 3.


Pre-procedure For full-face resurfacing, the author typically prescribes the following analgesic medications to be started on the day of treatment. One hour before treatment, the patient applies a thin layer of BLT Cream (Benzocaine 20%/ Lidocaine 6%/Tetracaine 4%) topical anaesthetic to the entire facial area. This is used with particular care at the periorbital areas and other lateral facial regions not easily covered by a regional block. For anxiety and analgesia, Valium (diazepam 5–10 mg


orally) and Tylex (co-codamol) to be given 45 minutes prior to the procedure, are usually prescribed. Every patient is prescribed Valtrex (valciclovir) 500 mg


twice daily for 8 days, starting 3 days before surgery. (The author noticed a <5% viral outbreak in over 450 patients before using strict anti-viral prophylaxis with every patient when using fractional devices.) If the patient had a strong history of acne, By-Mycin


(doxycycline 100 mg daily) or Augmentin-Duo (amoxicillin trihydrate/potassium clavulanate) was prescribed for 7 days, starting 1 day before surgery. If the patient had a history of frequent yeast infections, Diflucan (fluconazole 150 mg daily) was prescribed, starting 1 day before surgery. The author does not routinely prescribe antibiotic and antifungal medication. If just the periorbital area or neck are to be treated in isolation, no specific medication is usually prescribed.


Treatment procedure The patients were treated under topical and regional anaesthetic. IV sedation was not required for any patients, although 5 mg of midazolam can provide useful anxiolysis if required. For ActiveFX, the treatment parameters used were


density 3/9/5, 100–125 mJ, rate 125 Hz. The CPG was set to maximum size and an energy density of 2–5 depending on the area of the face being treated, as necks are treated at lower settings. The author used the square-shaped


Figure 3 (A) Prior to treatment, (B) 2 days post-treatment, and (C) 1-month post-treatment 52 ❚ October 2013 | prime-journal.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100